Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sofetabart mipitecan (LY4170156) for the treatment of adult patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have received prior bevacizumab and mirvetuximab soravtansine, if eligible. Sofetabart mipitecan is a […] The post Lilly’s sofetabart mipitecan receives U.S. FDA’s Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer appeared first on Web-Release.
We are pleased to inform you that the Award-winning Korean actor Park Bo-gum is now an OMEGA Brand Ambassador. In his new role, Park will represent the brand alongside globally renowned actors including George Clooney, Nicole Kidman, Eddie Redmayne, Naomi Harris, Daniel Craig, and Hyun Bin.